Streetbeat News

Regulatory

BDCC

Blackwell 3D Construction Corp. (OTC: BDCC) plans to file a Form 10 Registration Statement with the SEC, aiming to enhance transparency and increase shareholder confidence. The company will also cancel 25 million shares, indicating a strategic move towards growth as a publicly traded entity.

Portfolio Pulse from

November 12, 2024 | 2:30 pm

SONN

Sonnet BioTherapeutics has released a virtual investor segment discussing their recent U.S. patent issuance for a variant of IL-18, which is incorporated into their novel immunotherapeutic drug candidates, SON-1400 and SON-1411.

Portfolio Pulse from

November 12, 2024 | 2:30 pm

XOM

Exxon CEO Darren Woods advocates for the U.S. to remain involved in global climate change efforts, despite President-elect Donald Trump's previous withdrawal from the Paris climate agreement.

Portfolio Pulse from

November 12, 2024 | 2:30 pm

MIST

Milestone Pharmaceuticals has reported its third quarter 2024 financial results and provided updates on its regulatory and corporate activities. The New Drug Application (NDA) for CARDAMYST™ in paroxysmal supraventricular tachycardia (PSVT) is currently under review by the FDA, with a Prescription Drug User Fee Act (PDUFA) date set for March 27, 2025.

Portfolio Pulse from

November 12, 2024 | 2:15 pm

PHG

Philips has received FDA 510(k) clearance for its Spectral CT 7500 RT, a spectral 4DCT imaging system designed for radiation oncology. This advancement aims to enhance personalized cancer care by improving tumor visualization and treatment planning.

Portfolio Pulse from

November 12, 2024 | 2:15 pm

CVKD

Cadrenal Therapeutics presented tecarfarin data and a clinical trial protocol at the EACTS Medical Congress, focusing on its use in patients with the Abbott HeartMate3 LVAD.

Portfolio Pulse from

November 12, 2024 | 2:15 pm

SILS

Silver Scott Health, a division of Silver Scott Mines, Inc. (OTC PINK:SILS), anticipates significant opportunities in healthcare with the Trump Administration's potential overturning of the Affordable Healthcare Act.

Portfolio Pulse from

November 12, 2024 | 2:15 pm

PEGY

Pineapple Energy Inc. has regained compliance with Nasdaq's minimum bid price requirements, ensuring its continued listing on the Nasdaq Capital Market.

Portfolio Pulse from

November 12, 2024 | 2:00 pm

BDRX

Biodexa Pharmaceuticals PLC has regained compliance with Nasdaq's $1.00 minimum bid price requirement, ensuring its continued listing on the exchange.

Portfolio Pulse from

November 12, 2024 | 2:00 pm

ACNB

ACNB Corporation has received all necessary regulatory approvals to acquire Traditions Bancorp, Inc., marking a significant step in the acquisition process.

Portfolio Pulse from

November 12, 2024 | 1:45 pm